Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,381 to 1,400 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppressive Effects of a Truncated Inhibitor K562 Protein-Derived Peptide on Two Proinflammatory Cytokines, IL-17 and TNF-α. | J Microbiol Biotechnol | 2020 | 32958733 | PubTator, text mining | PubMed |
| Identification of clinical molecular targets for childhood Burkitt lymphoma. | Transl Oncol | 2020 | 32947237 | PubTator, text mining | PubMed |
| Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics? | Biomolecules | 2020 | 32933047 | PubTator, text mining | PubMed |
| Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. | Nat Genet | 2020 | 32929287 | PubTator, text mining | PubMed |
| Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future Prospects. | Clin Cosmet Investig Dermatol | 2020 | 32922059 | PubTator, text mining | PubMed |
| Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis. | Hum Genomics | 2020 | 32917282 | PubTator, text mining | PubMed |
| Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. | Cancer Cell | 2020 | 32916126 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. | Blood Cancer Discov | 2020 | 32914098 | PubTator, text mining | PubMed |
| Tackling Resistance to Cancer Immunotherapy: What Do We Know? | Molecules | 2020 | 32911646 | PubTator, text mining | PubMed |
| High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation. | Sci Rep | 2020 | 32901107 | PubTator, text mining | PubMed |
Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion. | Int J Mol Sci | 2020 | 32899940 | PubTator, text mining | PubMed |
| Targeting MHC Regulation Using Polycyclic Polyprenylated Acylphloroglucinols Isolated from Garcinia bancana. | Biomolecules | 2020 | 32887413 | PubTator, text mining | PubMed |
| RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A. | Sci Rep | 2020 | 32883983 | PubTator, text mining | PubMed |
| A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review. | Open Forum Infect Dis | 2020 | 32875002 | PubTator, text mining | PubMed |
| Differential contribution of bone marrow-derived infiltrating monocytes and resident macrophages to persistent lung inflammation in chronic air pollution exposure. | Sci Rep | 2020 | 32873817 | PubTator, text mining | PubMed |
| Type II interferon signaling in the brain during a viral infection with age-dependent pathogenesis. | Dev Neurobiol | 2020 | 32866337 | PubTator, text mining | PubMed |
| Assessment of tumor suppressor promoter methylation in healthy individuals. | Clin Epigenetics | 2020 | 32859265 | PubTator, text mining | PubMed |
| MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. | Science | 2020 | 32855215 | Swiss-Prot, curated | PubMed |
| Inactivating mutations of class II transactivator (CIITA) gene in gastric and colorectal cancers. | Pathol Res Pract | 2020 | 32853948 | PubTator, text mining | PubMed |
| Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial. | Lancet Haematol | 2020 | 32853585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=70